LeMaitre Vascular Price To Book vs. Net Income

LMAT Stock  USD 86.99  1.19  1.39%   
Considering LeMaitre Vascular's profitability and operating efficiency indicators, LeMaitre Vascular's profitability may be sliding down. It has an above-average probability of reporting lower numbers next quarter. Profitability indicators assess LeMaitre Vascular's ability to earn profits and add value for shareholders. At this time, LeMaitre Vascular's Price To Sales Ratio is comparatively stable compared to the past year. Days Sales Outstanding is likely to gain to 59.13 in 2026, whereas Operating Cash Flow Sales Ratio is likely to drop 0.1 in 2026. At this time, LeMaitre Vascular's Interest Income is comparatively stable compared to the past year. Net Interest Income is likely to gain to about 5.7 M in 2026, despite the fact that Accumulated Other Comprehensive Income is likely to grow to (5.3 M). At this time, LeMaitre Vascular's Gross Profit is comparatively stable compared to the past year. Pretax Profit Margin is likely to gain to 0.24 in 2026, whereas Gross Profit Margin is likely to drop 0.76 in 2026.
Current ValueLast YearChange From Last Year 10 Year Trend
Gross Profit Margin0.760.79
Sufficiently Down
Slightly volatile
For LeMaitre Vascular profitability analysis, we use financial ratios and fundamental drivers that measure the ability of LeMaitre Vascular to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well LeMaitre Vascular utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between LeMaitre Vascular's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of LeMaitre Vascular over time as well as its relative position and ranking within its peers.
Check out Correlation Analysis.
For more information on how to buy LeMaitre Stock please use our How to Invest in LeMaitre Vascular guide.The next projected EPS of LeMaitre Vascular is estimated to be 0.6189 with future projections ranging from a low of 0.54 to a high of 0.66. LeMaitre Vascular's most recent 12-month trailing earnings per share (EPS TTM) is at 2.32. Please be aware that the consensus of earnings estimates for LeMaitre Vascular is based on EPS before non-recurring items and includes expenses related to employee stock options.
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
LeMaitre Vascular is projected to generate 0.6189 in earnings per share on the 31st of March 2026. LeMaitre Vascular earnings estimates show analyst consensus about projected LeMaitre Vascular EPS (Earning Per Share). It derives the highest and the lowest estimates based on LeMaitre Vascular's historical volatility. Many public companies, such as LeMaitre Vascular, manage the perception of their earnings on a regular basis to make sure that analyst estimates are accurate. Future earnings calculations are also an essential input when attempting to value a firm. By analyzing LeMaitre Vascular's earnings estimates, investors can diagnose different trends across LeMaitre Vascular's analyst sentiment over time as well as compare current estimates against different timeframes.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of LeMaitre Vascular. If investors know LeMaitre will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about LeMaitre Vascular listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.536
Dividend Share
0.76
Earnings Share
2.32
Revenue Per Share
10.663
Quarterly Revenue Growth
0.114
The market value of LeMaitre Vascular is measured differently than its book value, which is the value of LeMaitre that is recorded on the company's balance sheet. Investors also form their own opinion of LeMaitre Vascular's value that differs from its market value or its book value, called intrinsic value, which is LeMaitre Vascular's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because LeMaitre Vascular's market value can be influenced by many factors that don't directly affect LeMaitre Vascular's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between LeMaitre Vascular's value and its price as these two are different measures arrived at by different means. Investors typically determine if LeMaitre Vascular is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, LeMaitre Vascular's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

LeMaitre Vascular Net Income vs. Price To Book Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining LeMaitre Vascular's current stock value. Our valuation model uses many indicators to compare LeMaitre Vascular value to that of its competitors to determine the firm's financial worth.
LeMaitre Vascular is rated fourth overall in price to book category among its peers. It is rated below average in net income category among its peers making up about  8,565,038  of Net Income per Price To Book. At this time, LeMaitre Vascular's Net Income is comparatively stable compared to the past year. Comparative valuation analysis is a catch-all technique that is used if you cannot value LeMaitre Vascular by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.

LeMaitre Net Income vs. Price To Book

Price to Book (P/B) ratio is used to relate a company book value to its current market price. A high P/B ratio indicates that investors expect executives to generate more returns on their investments from a given set of assets. Book value is the accounting value of assets minus liabilities.

LeMaitre Vascular

P/B

 = 

MV Per Share

BV Per Share

 = 
5.14 X
Price to Book ratio is mostly used in financial services industries where assets and liabilities are typically represented by dollars. Although low Price to Book ratio generally implies that the firm is undervalued, it is often a good indicator that the company may be in financial or managerial distress and should be investigated more carefully.
Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.

LeMaitre Vascular

Net Income

 = 

(Rev + Gain)

-

(Exp + Loss)

 = 
44.04 M
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.

LeMaitre Net Income Comparison

LeMaitre Vascular is currently under evaluation in net income category among its peers.

LeMaitre Vascular Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in LeMaitre Vascular, profitability is also one of the essential criteria for including it into their portfolios because, without profit, LeMaitre Vascular will eventually generate negative long term returns. The profitability progress is the general direction of LeMaitre Vascular's change in net profit over the period of time. It can combine multiple indicators of LeMaitre Vascular, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Last ReportedProjected for Next Year
Accumulated Other Comprehensive Income-5.6 M-5.3 M
Operating Income60.1 M63.1 M
Income Before Tax65.4 M68.7 M
Total Other Income Expense Net5.3 M5.6 M
Net Income50.6 M53.2 M
Income Tax Expense14.8 M15.5 M
Net Income Applicable To Common Shares23.7 M24.9 M
Net Income From Continuing Ops50.6 M53.2 M
Non Operating Income Net Other760.1 K798.2 K
Interest Income5.7 MM
Net Interest Income5.5 M5.7 M
Change To Netincome10 M10.5 M
Net Income Per Share 1.77  1.85 
Income Quality 0.90  0.95 
Net Income Per E B T 0.89  0.92 

LeMaitre Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on LeMaitre Vascular. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of LeMaitre Vascular position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the LeMaitre Vascular's important profitability drivers and their relationship over time.

LeMaitre Vascular Earnings Estimation Breakdown

The calculation of LeMaitre Vascular's earning per share is based on the data from the past 12 consecutive months, used for reporting the company's financial figures. The next projected EPS of LeMaitre Vascular is estimated to be 0.6189 with the future projection ranging from a low of 0.54 to a high of 0.66. Please be aware that this consensus of annual earnings estimates for LeMaitre Vascular is based on EPS before non-recurring items and includes expenses related to employee stock options.
Last Reported EPS
0.0
0.54
Lowest
Expected EPS
0.6189
0.66
Highest

LeMaitre Vascular Earnings Projection Consensus

Suppose the current estimates of LeMaitre Vascular's value are higher than the current market price of the LeMaitre Vascular stock. In this case, investors may conclude that LeMaitre Vascular is overpriced and will exhibit bullish sentiment. On the other hand, if the present value is lower than the stock price, analysts may conclude that the market undervalues the equity. These scenarios may suggest that the market is not as efficient as it should be at the estimation time, and LeMaitre Vascular's stock will quickly adjusts to the new information provided by the consensus estimate.
Number of AnalystsHistorical AccuracyLast Reported EPSEstimated EPS for 31st of March 2026Current EPS (TTM)
1185.59%
0.0
0.6189
2.32

LeMaitre Vascular Earnings History

Earnings estimate consensus by LeMaitre Vascular analysts from Wall Street is used by the market to judge LeMaitre Vascular's stock performance. Investors also use these earnings estimates to evaluate and project the stock performance into the future in order to make their investment decisions. However, we recommend analyzing not only LeMaitre Vascular's upcoming profit reports and earnings-per-share forecasts but also comparing them to our different valuation methods.

LeMaitre Vascular Quarterly Gross Profit

45.95 Million

At this time, LeMaitre Vascular's Retained Earnings are comparatively stable compared to the past year. Retained Earnings Total Equity is likely to gain to about 118.1 M in 2026, whereas Earnings Yield is likely to drop 0.01 in 2026. Net Income Applicable To Common Shares is likely to gain to about 24.9 M in 2026, whereas Common Stock Shares Outstanding is likely to drop slightly above 17.6 M in 2026.
Hype
Prediction
LowEstimatedHigh
85.5287.0088.48
Details
Intrinsic
Valuation
LowRealHigh
78.2994.8796.35
Details
11 Analysts
Consensus
LowTargetHigh
94.34103.67115.07
Details
Earnings
Estimates (0)
LowProjected EPSHigh
0.540.620.66
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as LeMaitre Vascular. Your research has to be compared to or analyzed against LeMaitre Vascular's peers to derive any actionable benefits. When done correctly, LeMaitre Vascular's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in LeMaitre Vascular. Note that many institutional investors and large investment bankers can move markets due to the volume of LeMaitre assets they manage. They also follow analysts to some degree and often drive overall investor sentiments towards LeMaitre Vascular. With so many stockholders watching consensus numbers, the difference between actual and projected earnings is one of the most critical factors driving LeMaitre Vascular's stock price in the short term.

LeMaitre Vascular Earnings per Share Projection vs Actual

Actual Earning per Share of LeMaitre Vascular refers to what the company shows during its earnings calls or quarterly reports. The Expected EPS is what analysts covering LeMaitre Vascular predict the company's earnings will be in the future. The higher the earnings per share of LeMaitre Vascular, the better is its profitability. While calculating the Earning per Share, we use the weighted ratio, as the number of shares outstanding can change over time.

LeMaitre Vascular Estimated Months Earnings per Share

For an investor who is primarily interested in generating an income out of investing in entities such as LeMaitre Vascular, the EPS ratio can tell if the company is intending to increase its current dividend. Although EPS is an essential tool for investors, it should not be used in isolation. EPS of LeMaitre Vascular should always be considered in relation to other companies to make a more educated investment decision.

LeMaitre Quarterly Analyst Estimates and Surprise Metrics

Earnings surprises can significantly impact LeMaitre Vascular's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
null
nullnullnullnull
2025-11-06
2025-09-300.570.620.05
2025-07-30
2025-06-300.56670.60.0333
2025-04-30
2025-03-310.49780.48-0.0178
2025-02-25
2024-12-310.490.490.0
2024-10-31
2024-09-300.440.490.0511 
2024-08-01
2024-06-300.470.520.0510 
2024-05-02
2024-03-310.390.440.0512 
2024-02-27
2023-12-310.360.380.02
2023-11-01
2023-09-300.30.330.0310 
2023-08-01
2023-06-300.320.360.0412 
2023-05-02
2023-03-310.250.270.02
2023-02-23
2022-12-310.260.25-0.01
2022-10-27
2022-09-300.280.25-0.0310 
2022-07-28
2022-06-300.270.16-0.1140 
2022-04-28
2022-03-310.280.27-0.01
2022-02-24
2021-12-310.310.28-0.03
2021-10-28
2021-09-300.330.3-0.03
2021-07-29
2021-06-300.340.40.0617 
2021-04-29
2021-03-310.270.280.01
2021-02-25
2020-12-310.290.340.0517 
2020-10-29
2020-09-300.190.370.1894 
2020-07-23
2020-06-300.010.210.22000 
2020-04-30
2020-03-310.150.160.01
2020-02-06
2019-12-310.230.230.0
2019-10-23
2019-09-300.210.250.0419 
2019-07-24
2019-06-300.210.230.02
2019-05-01
2019-03-310.190.17-0.0210 
2019-02-19
2018-12-310.20.30.150 
2018-10-04
2018-09-300.210.210.0
2018-07-26
2018-06-300.420.21-0.2150 
2018-04-25
2018-03-310.210.19-0.02
2018-02-21
2017-12-310.20.210.01
2017-10-26
2017-09-300.20.250.0525 
2017-07-27
2017-06-300.170.230.0635 
2017-04-26
2017-03-310.130.160.0323 
2017-02-21
2016-12-310.150.13-0.0213 
2016-10-26
2016-09-300.150.170.0213 
2016-07-27
2016-06-300.110.140.0327 
2016-05-02
2016-03-310.10.110.0110 
2016-02-24
2015-12-310.090.130.0444 
2015-10-27
2015-09-300.080.10.0225 
2015-07-28
2015-06-300.070.10.0342 
2015-04-28
2015-03-310.050.080.0360 
2015-02-25
2014-12-310.070.110.0457 
2014-10-28
2014-09-300.050.050.0
2014-07-29
2014-06-300.050.090.0480 
2014-04-29
2014-03-310.020.01-0.0150 
2014-02-25
2013-12-310.050.050.0
2013-10-29
2013-09-300.040.050.0125 
2013-07-30
2013-06-300.050.060.0120 
2013-05-01
2013-03-310.030.050.0266 
2013-02-26
2012-12-310.050.04-0.0120 
2012-10-30
2012-09-300.040.040.0
2012-07-31
2012-06-300.040.050.0125 
2012-05-02
2012-03-310.040.02-0.0250 
2012-02-27
2011-12-310.060.02-0.0466 
2011-10-27
2011-09-300.070.06-0.0114 
2011-07-28
2011-06-300.080.07-0.0112 
2011-04-28
2011-03-310.050.050.0
2011-02-28
2010-12-310.060.110.0583 
2010-10-28
2010-09-300.080.090.0112 
2010-07-28
2010-06-300.060.090.0350 
2010-04-29
2010-03-310.050.060.0120 
2009-10-28
2009-09-300.010.080.07700 
2009-07-29
2009-06-300.030.060.03100 
2009-04-28
2009-03-31-0.17-0.120.0529 
2008-10-29
2008-09-30-0.03-0.010.0266 
2008-07-29
2008-06-30-0.05-0.06-0.0120 
2008-04-30
2008-03-31-0.08-0.17-0.09112 
2008-03-04
2007-12-31-0.04-0.08-0.04100 
2007-11-05
2007-09-30-0.05-0.09-0.0480 
2007-08-01
2007-06-30-0.040.010.05125 
2007-05-03
2007-03-31-0.03-0.04-0.0133 
2007-02-28
2006-12-31-0.05-0.050.0

Use LeMaitre Vascular in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if LeMaitre Vascular position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in LeMaitre Vascular will appreciate offsetting losses from the drop in the long position's value.

LeMaitre Vascular Pair Trading

LeMaitre Vascular Pair Trading Analysis

The ability to find closely correlated positions to LeMaitre Vascular could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace LeMaitre Vascular when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back LeMaitre Vascular - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling LeMaitre Vascular to buy it.
The correlation of LeMaitre Vascular is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as LeMaitre Vascular moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if LeMaitre Vascular moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for LeMaitre Vascular can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your LeMaitre Vascular position

In addition to having LeMaitre Vascular in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Farming Thematic Idea Now

Farming
Farming Theme
Companies producing farming products and providing services for farmers. The Farming theme has 27 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Farming Theme or any other thematic opportunities.
View All  Next Launch

Additional Tools for LeMaitre Stock Analysis

When running LeMaitre Vascular's price analysis, check to measure LeMaitre Vascular's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy LeMaitre Vascular is operating at the current time. Most of LeMaitre Vascular's value examination focuses on studying past and present price action to predict the probability of LeMaitre Vascular's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move LeMaitre Vascular's price. Additionally, you may evaluate how the addition of LeMaitre Vascular to your portfolios can decrease your overall portfolio volatility.